Effects of Endothelin-1 on Metals in Diabetic Rats
Author Information
Author(s): Lu Cai, Shali Chen, Terry Evans, M. George Cherian, Subrata Chakrabarti
Primary Institution: The University of Western Ontario
Hypothesis
The study investigates whether chronic diabetes affects metallothionein expression in the liver and kidney through an endothelin-1 dependent pathway.
Conclusion
The study found that endothelin-1 influences metallothionein levels and trace metal accumulation in the liver and kidneys of diabetic rats.
Supporting Evidence
- Increased hepatic metallothionein levels were associated with decreased hepatic copper and iron in diabetic rats.
- Bosentan treatment partially prevented the increase in metallothionein levels in both liver and kidney.
- Diabetic rats showed increased serum creatinine levels, which were corrected by bosentan treatment.
Takeaway
In diabetic rats, a substance called endothelin-1 changes how certain proteins and metals behave in the liver and kidneys, which might affect their health.
Methodology
The study used diabetic and control rats, measuring metallothionein and trace metals in liver and kidney tissues after treatment with bosentan.
Limitations
The study was limited to male Sprague-Dawley rats and may not be generalizable to other populations.
Participant Demographics
Male Sprague-Dawley rats, approximately 200 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website